Phase 3 Psoriatic Arthritis Clinical Trials
11 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–11 of 11 trials
Recruiting
Phase 3
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
Psoriatic ArthritisModerate to Severe Plaque Psoriasis
UCB Biopharma SRL90 enrolled16 locationsNCT06506916
Recruiting
Phase 3
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Active Juvenile Psoriatic Arthritis
Amgen60 enrolled45 locationsNCT04804553
Recruiting
Phase 3
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Juvenile Psoriatic Arthritis
Bristol-Myers Squibb60 enrolled47 locationsNCT06869551
Recruiting
Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Psoriatic Arthritis
Takeda600 enrolled122 locationsNCT06671496
Recruiting
Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Takeda1,088 enrolled189 locationsNCT06671483
Recruiting
Phase 2Phase 3
A Study of Picankibart in Patients With Active Psoriatic Arthritis
Psoriatic Arthritis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.222 enrolled1 locationNCT07295509
Recruiting
Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic Arthritis
Takeda1,182 enrolled1 locationNCT07286058
Recruiting
Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Juvenile Psoriatic Arthritis
AbbVie40 enrolled31 locationsNCT06100744
Recruiting
Phase 3
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Juvenile Psoriatic ArthritisBehçet's Disease
Amgen48 enrolled7 locationsNCT05767047
Recruiting
Phase 3
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Psoriatic Arthritis
University of Pennsylvania63 enrolled14 locationsNCT05669833
Recruiting
Phase 3
A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis
Psoriatic Arthritis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.200 enrolled1 locationNCT06640257